Ali Faraz 4
4 · Tenaya Therapeutics, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Tenaya Therapeutics (TNYA) CEO Ali Faraz Sells Shares
What Happened
Ali Faraz, CEO of Tenaya Therapeutics, sold a total of 14,862 shares in open-market transactions on February 17, 2026. The shares were sold at prices ranging from $0.6075 to $0.671 (weighted average $0.64), generating total proceeds of $9,557. These sales were made to satisfy tax withholding obligations tied to vested restricted stock units (RSUs), not as independent discretionary stock sales.
Key Details
- Transaction date: 2026-02-17 (filed same day).
- Sales: 5,851 shares for $3,762; 3,979 shares for $2,559; 5,032 shares for $3,236 — total 14,862 shares for $9,557.
- Price range: $0.6075 – $0.671; weighted average price reported $0.64 (footnote notes detailed per-price breakdown available on request).
- Reason: Shares sold to cover tax withholding on RSU vestings (footnotes reference RSU awards from Feb 15, 2023; Feb 23, 2024; Feb 6, 2025).
- Ownership note: The filing discloses unvested RSUs that will convert to common stock — footnotes list 354,250; 343,625; and 330,187 shares tied to different award grants (totaling 1,028,062 RSU shares) that are included in beneficial ownership disclosure. The Form 4 does not separately list a simple “shares owned after transaction” total for fully vested shares in the items you provided.
- Timeliness: Report appears to have been filed on the transaction date (not late).
Context
Sales labeled as tax-withholding (cashless) for RSU vesting are routine and common for executives; they do not necessarily indicate a change in the insider’s view of the company. This transaction code is F (tax withholding) / S (sale) rather than a discretionary open-market sell for investment reasons.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-02-17$0.64/sh−5,851$3,762→ 452,415 total - Sale
Common Stock
[F4][F2][F5]2026-02-17$0.64/sh−3,979$2,559→ 448,436 total - Sale
Common Stock
[F6][F2][F7]2026-02-17$0.64/sh−5,032$3,236→ 443,404 total
Footnotes (7)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 354,250 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
- [F5]Includes 343,625 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F6]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
- [F7]Includes 330,187 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.